Navigation Links
MULTI-LINK OTW PENTA Coronary Stent System

ProductsMULTI-LINK OTW PENTA Coronary Stent System
Company Guidant Corporation
Item MULTI-LINK OTW PENTA Coronary Stent System
Features Consistent cell size and rounded struts for easy access. Corrugated ring design together with ACCESS-LINK Technology allows for good stent cell expansion. THE WRAP Balloon with S.T.E.P. Technology provides improved re-wrap and lower profile upon deflation for smooth pullback into 5F guides. S.T.E.P. Technology minimizes vessel Dialation outside the stent upon expansion.
Description The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter.
Info Guidant Corporation
Customer Service: (317) 971-2000
Web site: http://www.guidant.com/

Related medicine products :

1. MULTI-LINK OTW PIXEL Coronary Stent System
2. MULTI-LINK RX PIXEL Coronary Stent System
3. MULTI-LINK OTW ZETA Coronary Stent System
4. MULTI-LINK RX PENTA Coronary Stent System
5. MULTI-LINK RX ZETA Coronary Stent System
6. MULTI-LINK OTW ULTRA Coronary Stent System
7. MULTI-LINK RX ULTRA Coronary Stent System
8. MULTI-LINK MINI VISIONCoronary Stent System
9. Atlantis SR Pro Coronary Imaging Catheter
10. Cypher Sirolimus-eluting Coronary Stent
11. Express Coronary Stent System
Panoramic styling that contours closely to the face and brow. Saddle bridge fits average to fuller noses. Adjustable temple hinge adjusts up or down, longer or shorter. Soft cushion behind ear for co...
... Both lenses and frames are designed with ... mind. Our lenses are Schott RS-520 (also called ... shielding glass. These lenses meet standards, as set ... prism correction. ,While our eyewear is protecting ...
Qualcraft™ Radiation Protection Eyewear, Metal, Bifocal. Provides maximum comfort and eye protection! Plano (nonprescription). Black with bronze temple bar....
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
Medicine Products:
(Date:6/23/2017)... ... June 23, 2017 , ... American Farmer, will feature Chr. Hansen, Inc ... to air fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check ... founded Chr. Hansen in Denmark in 1874 after a groundbreaking discovery of how to ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... the Houston area with access to asset protection and financial planning services, is ... aimed at improving the lives of children with cancer and other chronic diseases. ...
(Date:6/22/2017)... (PRWEB) , ... June 22, 2017 , ... ... advisory organization, is pleased to welcome Whipple & Company as its newest Partner ... clear purpose of balancing their clients’ risk while tailoring optimized benefit packages that ...
(Date:6/22/2017)... ... 2017 , ... Despite its pervasiveness, many physicians are unfamiliar with how best ... with clinical practice. Now, however, a timely review has been published in the ... etiology of NeuP and educating preclinical scientists on its diagnosis and choice of treatment. ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... -- Enterin Inc., a privately-held CNS pharmaceutical company based in ... treat Parkinson,s disease (PD), has enrolled the first patient in ... controlled, multicenter study involving patients with PD and taking place ... a 9-to-12-month period. The first stage is open label and ... sites include Denver , Boca ...
Breaking Medicine Technology: